Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Home | Events | Distinguished Seminar

For these events, a scientist of international standing is invited to conduct a seminar or otherwise interact with the CNIO’s team of researchers. Several of these are scheduled over the course of the year and are open to the public. Participants come from different fields, literature and technology included. The aim is to create a stimulating environment that helps to clear minds of stale thoughts and replace them with new ideas.

Download poster as PDF

Distinguished Seminar 12/04/2024
Ailong Ke
New Frontiers in CRISPR-Cas Biology – RNA-guided Proteases and Ancestorial Cas9s in Transposons
Distinguished Seminar 22/03/2024
Andrés Hidalgo
Multidimensional neutrophils
Distinguished Seminar 15/03/2024
Joseph Schlessinger
Cell Signaling By Receptor Tyrosine Kinases; From Basic Principles To Cancer Therapies
Distinguished Seminar 08/03/2024
Lindsay Hinck
Consequences of Physiological DNA Damage in the Breast and Uterus
Distinguished Seminar 23/02/2024
Sjors Scheres
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Distinguished Seminar 16/02/2024
Mariam Jamal-Hanjani
Insights into lung cancer evolution and metastasis in TRACERx and PEACE
Distinguished Seminar 09/02/2024
Cristina Mayor
Targeted protein degradation: drug discovery opportunities & overcoming resistance mechanisms in cancer
Distinguished Seminar 15/12/2023
Victoria Sanz-Moreno
Finding vulnerabilities in metastatic cancer cells
Distinguished Seminar 01/12/2023
Stefan Knapp
Targeting strategies for the development of highly selective allosteric and orthosteric kinase inhibitors
Distinguished Seminar 17/11/2023
Joseph Takahashi
Role of Circadian Clocks in Healthspan and Lifespan in Mice
Distinguished Seminar 03/11/2023
Walid Khaled
Tumour Initiation Through Aberrant Differentiation: Lessons from Single Cell Genomics
Distinguished Seminar 27/10/2023
Marta María Alonso Roldán
Locking TIM3 as a therapeutic strategy for pediatric diffuse midline Glioma

Up